Union Korea Pharm Co., Ltd. (KOSDAQ:080720)

South Korea · Delayed Price · Currency is KRW

2,725.00

-310.00 (-10.21%)

At close: Oct 11, 2024

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Manufacturing and Selling Pharmaceutical Products	51.28B	63.17B	61.29B	48.30B	50.38B
Manufacturing and Selling Pharmaceutical Products Growth	-18.82%	3.06%	26.89%	-4.12%	-1.73%
Total	51.28B	63.17B	61.29B	48.30B	50.38B
Total Growth	-18.82%	3.06%	26.89%	-4.12%	-1.73%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea	48.26B	60.91B	58.96B	46.55B	46.67B
South Korea Growth	-20.77%	3.32%	26.65%	-0.25%	-1.66%
Overseas	3.02B	2.26B	2.34B	1.75B	3.71B
Overseas Growth	33.71%	-3.40%	33.41%	-52.76%	-2.60%
Total	51.28B	63.17B	61.29B	48.30B	50.38B
Total Growth	-18.82%	3.06%	26.89%	-4.12%	-1.73%

Source: S&P Global Market Intelligence.